Hemispherx (HEB) Enters New Alferon N Injection Agreement with Armada Health Care
Tweet
Share
E-mailGet Alerts HEB Hot Sheet
Join SI Premium – FREE
Hemispherx Biopharma, Inc. (AMEX: HEB), has entered into a new agreement with Armada Health Care, LLC, for the sales/marketing of Alferon N Injection, its Federal Drug Administration-approved natural interferon, in the U.S.
Under this Agreement, the Company will manufacture and supply Alferon N Injection to physicians and patients through Armada's national network of specialty pharmacies.
Under this Agreement, the Company will manufacture and supply Alferon N Injection to physicians and patients through Armada's national network of specialty pharmacies.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA authorizes 11 ZYN Ultra nicotine pouches for Philip Morris
- Denarius Metals acquires 15% stake in Copper Giant, Trafigura invests
- Lazard Global Total Return fund declares $0.1534 monthly distribution
Create E-mail Alert Related Categories
Corporate News, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
